[U.S. Stock Market Movement] OPKO Health surged on October 15: Labcorp acquisition + BioReference

OPKO Health Soared on October 15—Analysis

Keywords: Labcorp Acquisition, BioReference

1. On October 15, OPKO Health announced that it had reached an agreement with Labcorp for Labcorp to acquire certain assets of its wholly owned subsidiary, BioReference Health, with $722 million in cash to be paid at the closing of the transaction.

2. On October 15, the assets to be acquired include clinical and women’s health, urology testing services, over 80 patient service centers, and the FDA-approved 4Kscore prostate cancer blood test; Labcorp may also pay up to an additional $150 million based on 4Kscore revenues.

(Disclaimer: This content is generated by AI technology summarizing publicly available information, for reference only and does not constitute investment advice.)